Status:
WITHDRAWN
Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic
Lead Sponsor:
Universiti Sains Malaysia
Conditions:
Human Papilloma Virus Infection
Eligibility:
FEMALE
26+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy of oral administration of probiotic at 9 log colony forming unit (CFU)/day to reduce vaginal abundance of HPV in women compared to placebo via the...
Detailed Description
Probiotics have shown an antiviral activity and several mechanisms have been demonstrated. In respiratory tract infections (RTIs), the majority of probiotics can inhibit the most important respiratory...
Eligibility Criteria
Inclusion
- Sexually active women
- Age above 26 years old
- Determined as HPV positive against L1 variant
- Willing to commit throughout the experiment
Exclusion
- On long term medication (6 months and above) for any illnesses
- Pregnant
- Uterus and/or cervix removed
- Prior HPV vaccination
- Cervical intraepithelial neoplasia
Key Trial Info
Start Date :
December 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05316064
Start Date
December 27 2021
End Date
November 28 2023
Last Update
May 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Seberang Jaya
Pulau Pinang, Pulau Pinang, Malaysia, 13700